Oppilotech and Evariste Technologies Announce Partnership to Develop First-in-Class Antibacterial Programme MD Bureau20 March 2022 4:45 PM ISTOppilotech Ltd, a biotech specialising in systems biology and machine learning platforms to build unique predictive computational models of cells,...
Bristol Myers gets USFDA approval for First LAG-3-Blocking Antibody Combination, Opduala MD Bureau20 March 2022 2:30 PM ISTThe trial met its primary endpoint, progression-free survival, and Opdualag more than doubled the median PFS when compared to nivolumab monotherapy,...
Moderna submits amendment to USFDA for its COVID-19 vaccine booster dose MD Bureau20 March 2022 2:15 PM ISTThe U.S. FDA approved the Biologics License Application (BLA) for SPIKEVAX (COVID-19 Vaccine, mRNA) to prevent COVID-19 in individuals 18 years of age...
Bayer applies in EU for extension of Indication to Finerenone MD Bureau20 March 2022 1:00 PM ISTThe submission is based on positive data from the FIGARO-DKD study, which demonstrated that finerenone significantly reduced the risk of...
Labcorp gets CDSCO nod to conduct a study on anticancer drug Dr. Divya Colin20 March 2022 11:15 AM ISTNew Delhi: In a significant development, Labcorp, a leading global life sciences company, has received approval from the Central Drugs Standard...
IQVIA gets CDSCO panel nod to conduct study of ASLAN004 for atopic dermatitis Dr. Divya Colin20 March 2022 10:15 AM ISTNew Delhi: Drug maker IQVIA has got approval from the Central Drugs Standard Control Organization (CDSCO) to conduct a Phase IIb clinical trial of...
Bristol Myers sues AstraZeneca over cancer-treatment patents MD Bureau19 March 2022 6:08 PM ISTBristol asked the Delaware court for an undisclosed amount of monetary damages.
Marinus Pharma gets USFDA nod for ZTALMY for CDKL5 deficiency disorder MD Bureau19 March 2022 2:53 PM ISTCDD is a serious and rare genetic disorder characterized by early-onset, difficult-to-control seizures and severe neuro-developmental impairment. It's...
Synokem gets CDSCO panel nod to market FDC Nortriptyline, Pregabalin Dr. Divya Colin19 March 2022 2:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted permission to drug...
Jubilant Pharma announces the development of a novel oral formulation of Remdesivir in animals MD Bureau19 March 2022 2:22 PM ISTThis innovative formulation is likely to ease the capacity constraint that injectable formulation faces and ensure wider and timely availability for...
Unichem Laboratories gets USFDA approval for its Nebivolol Tablets MD Bureau19 March 2022 2:22 PM ISTUnichem Laboratories Limited is pleased to announce that it has received ANDA approval for its Nebivolol Tablets 2.5 mg, 5 mg, 10 mg, and 20 mg from...
Digital health platform Tata 1mg launches its first Reference Lab in Delhi MD Bureau18 March 2022 5:00 PM ISTTata 1mg, India's largest digital health platform today announced the launch of its first Reference Lab based in Delhi, which was inaugurated by Dr....
